Isofol Medical AB (publ) (STO:ISOFOL)
Sweden · Delayed Price · Currency is SEK 0.8150
+0.0290 (3.69%)
Oct 13, 2026, 12:40 PM CET
Isofol Medical AB Market Cap
Isofol Medical AB has a market cap or net worth of 261.2 million as of October 12, 2026. It is the 35,419th most valuable company in the world and the 481st biggest in Sweden. Its market cap has increased by 26.42% in one year.
Market Cap
261.20M
Enterprise Value
146.37M
Revenue
n/a
Global Rank
Country Rank
#481 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since April 4, 2017, Isofol Medical AB's market cap has decreased from 853.32M to 261.20M, a decrease of -69.39%. That is a compound annual growth rate of -11.68%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2026 | 261.20M | 27.46% |
| Dec 30, 2025 | 204.93M | -42.85% |
| Dec 30, 2024 | 358.56M | 204.11% |
| Dec 29, 2023 | 117.91M | -1.35% |
| Dec 30, 2022 | 119.52M | -91.99% |
| Dec 30, 2021 | 1.49B | -36.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 4, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Cantargia AB | 386.26M |
| Sprint Bioscience AB | 385.13M |
| Mendus AB | 381.31M |
| Corline Biomedical AB | 358.02M |
| Intervacc AB | 302.30M |
| Xbrane Biopharma AB | 287.44M |
| IRLAB Therapeutics AB | 253.70M |
| Elicera Therapeutics AB | 183.86M |